Monitoring Approaches for a Pediatric Chronic Kidney Disease Machine Learning Model

Keith E Morse1, Conner Brown2, Scott Fleming3

  • 1Division of Pediatric Hospital Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, United States.

Insights

Monitoring metrics can detect performance drops in deployed chronic kidney disease (CKD) risk models. Standardized mean differences and other analyses flagged issues, indicating potential for early detection of model deterioration.

Area of Science:

  • Health Informatics
  • Clinical Decision Support
  • Machine Learning in Healthcare

Background:

  • Clinical decision support tools, such as chronic kidney disease (CKD) risk models, require ongoing performance monitoring after deployment.
  • Ensuring the reliability of predictive models in real-world clinical settings is crucial for patient care.

Purpose of the Study:

  • To evaluate the effectiveness of three distinct metrics in detecting performance degradation of a deployed CKD risk model.
  • To assess the utility of standardized mean differences (SMDs), a membership model, and response distribution analysis for monitoring model performance.

Main Methods:

  • A CKD risk model, initially developed on retrospective data, was silently deployed on new patient admissions.
  • Three monitoring metrics (SMDs, membership model, response distribution analysis) were applied during the silent deployment phase.
  • Prospective model performance was calculated using observed outcomes to assess the metrics' ability to detect changes.

Main Results:

  • The deployed CKD model showed a significant performance decrease (AUROC 0.63) compared to retrospective data (AUROC 0.76).
  • SMDs revealed significant differences in 88% of input variables between retrospective and deployment data (p <0.05).
  • The membership model (AUROC 0.71) and response distribution analysis both effectively discriminated between retrospective and deployment settings (p <0.0001).

Conclusions:

  • The evaluated metrics, including SMDs, membership models, and response distribution analysis, show promise for early detection of performance decline in deployed predictive models.
  • These monitoring strategies can help ensure the continued accuracy and reliability of clinical decision support tools.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
91
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
66
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
85
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
116
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
54
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
172